Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pramiracetam

Copy Product Info
🥰Excellent
Catalog No. T0183Cas No. 68497-62-1
Alias CI-879

Pramiracetam (CI-879), derived from piracetam, is a more effective nootropic drug . According to reports, Pramiracetam improved cognitive defects related with traumatic brain wounds. Pramiracetam was also potent in the therapy of cognitive disorders of traumatic origins and cerebrovascular.

Pramiracetam

Pramiracetam

Copy Product Info
🥰Excellent
Purity: 99.94%
Catalog No. T0183Alias CI-879Cas No. 68497-62-1
Pramiracetam (CI-879), derived from piracetam, is a more effective nootropic drug . According to reports, Pramiracetam improved cognitive defects related with traumatic brain wounds. Pramiracetam was also potent in the therapy of cognitive disorders of traumatic origins and cerebrovascular.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$38In StockIn Stock
100 mg$58In StockIn Stock
200 mg$93In StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.94%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Pramiracetam AI Summary
Pramiracetam demonstrates the ability to reverse electroconvulsive shock-induced amnesia in mice, with the percentage of amnesia reversal ranging from 0.0% at 0.63 mg/kg to 96.0% at 5 mg/kg. However, the effectiveness decreases at a dose of 20.0 mg/kg and significantly drops at 80.0 mg/kg. Additionally, this compound shows bioactivity in inhibiting Plasmodium falciparum (DD2) proliferation with a potency of 7492.9 nM. In terms of antiviral activity, Pramiracetam has demonstrated low to negligible effectiveness against SARS-CoV-2 induced cytotoxicity in various assays and cell models, including Caco-2 and VERO-6 cells, with inhibition percentages ranging from -0.12% to a maximum IC50 value greater than 20000.0 nM. The compound also inhibits the SARS-CoV-2 3CL-Pro protease with varying inhibition percentages. Moreover, it exhibits inhibitory activity on the human HDAC6 enzyme, decreasing enzyme activity by 31.7% with a commercial peptide substrate and by 8.52% with a custom peptide substrate. However, the compound showed no significant bioactivity in assays conducted for various other targets, with all AC50 values being greater than 30000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Pramiracetam (CI-879), derived from piracetam, is a more effective nootropic drug . According to reports, Pramiracetam improved cognitive defects related with traumatic brain wounds. Pramiracetam was also potent in the therapy of cognitive disorders of traumatic origins and cerebrovascular.
SynonymsCI-879
Chemical Properties
Molecular Weight269.38
FormulaC14H27N3O2
Cas No.68497-62-1
SmilesC(C(NCCN(C(C)C)C(C)C)=O)N1C(=O)CCC1
Relative Density.1.036 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (185.61 mM), Sonication is recommended.
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.42 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7122 mL18.5611 mL37.1223 mL185.6114 mL
5 mM0.7424 mL3.7122 mL7.4245 mL37.1223 mL
10 mM0.3712 mL1.8561 mL3.7122 mL18.5611 mL
20 mM0.1856 mL0.9281 mL1.8561 mL9.2806 mL
50 mM0.0742 mL0.3712 mL0.7424 mL3.7122 mL
100 mM0.0371 mL0.1856 mL0.3712 mL1.8561 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Pramiracetam | purchase Pramiracetam | Pramiracetam cost | order Pramiracetam | Pramiracetam chemical structure | Pramiracetam formula | Pramiracetam molecular weight